XML 53 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
Statements of Operations (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Product sales, net $ 10,333,090us-gaap_SalesRevenueGoodsNet $ 10,011,420us-gaap_SalesRevenueGoodsNet
Cost of products sold 3,630,765us-gaap_CostOfGoodsSold 3,198,908us-gaap_CostOfGoodsSold
Gross profit 6,702,325us-gaap_GrossProfit 6,812,512us-gaap_GrossProfit
Selling, general and administrative expenses 7,404,258us-gaap_SellingGeneralAndAdministrativeExpense 5,534,463us-gaap_SellingGeneralAndAdministrativeExpense
Research and development expenses 88,243us-gaap_ResearchAndDevelopmentExpense 191,345us-gaap_ResearchAndDevelopmentExpense
Total operating expenses 7,492,501us-gaap_OperatingExpenses 5,725,808us-gaap_OperatingExpenses
(Loss) income from operations (790,176)us-gaap_OperatingIncomeLoss 1,086,704us-gaap_OperatingIncomeLoss
Other income (expense)    
Other income   17,543us-gaap_OtherNonoperatingIncome
Interest income 5,057us-gaap_InvestmentIncomeInterest 115us-gaap_InvestmentIncomeInterest
Interest expense (2,668)us-gaap_InterestExpense (70,801)us-gaap_InterestExpense
Gain on Dilutive Effect on Medical Joint Venture stock issuance   1,363,650us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
Total other expense, net (907,811)us-gaap_NonoperatingIncomeExpense 378,226us-gaap_NonoperatingIncomeExpense
(Loss) income before provision for income taxes (1,697,987)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 1,464,930us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Provision for Income Tax 9,509us-gaap_IncomeTaxExpenseBenefit  
Net (loss) income (1,707,496)us-gaap_ProfitLoss 1,464,930us-gaap_ProfitLoss
Less: Net loss attributable to the noncontrolling interest 5,472us-gaap_NetIncomeLossAttributableToNoncontrollingInterest  
Net (loss) income attributable to Milestone Scientific Inc. (1,702,024)us-gaap_NetIncomeLoss 1,464,930us-gaap_NetIncomeLoss
Net (loss) income per share applicable to common stockholders -    
Basic $ (0.08)us-gaap_EarningsPerShareBasic $ 0.09us-gaap_EarningsPerShareBasic
Diluted $ (0.08)us-gaap_EarningsPerShareDiluted $ 0.08us-gaap_EarningsPerShareDiluted
Weighted average shares outstanding and to be issued -    
Basic 20,063,513us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 17,127,468us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Diluted 20,063,513us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 17,483,638us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
Medical Joint Venture    
Other income (expense)    
Loss on Earnings from joint venture (891,500)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
(924,363)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
Education Joint Venture    
Other income (expense)    
Loss on Earnings from joint venture (17,890)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_EducationJointVentureMember
(7,918)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_EducationJointVentureMember
China Joint Venture    
Other income (expense)    
Loss on Earnings from joint venture $ (810)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_ChinaJointVentureMember